{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:03:32Z","timestamp":1780041812614,"version":"3.53.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.prro.2025.10.003","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:57:40Z","timestamp":1762307860000},"page":"176-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiation Therapy Outcomes of the National Protocol in Childhood Neuroblastomas: Turkish Society for Radiation Oncology Hematological Oncology, Pediatric Oncology, and TBI Working Group Study (TROD 03-004)"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1806-2619","authenticated-orcid":false,"given":"Melis","family":"Gultekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9813-9286","authenticated-orcid":false,"given":"Melek Tugce","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferah","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serra","family":"Kamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Nur","family":"Demiral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilge","family":"Gursel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Gural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulya","family":"Agaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumerya","family":"Duru Birgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuslat","family":"Yurut Caloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur","family":"Olgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Aksoylar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Anacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2025.10.003_bib0001","first-page":"284","article-title":"Nervous system: Embryonal tumors: Neuroblastoma","volume":"24","author":"Pudela","year":"2020","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"10.1016\/j.prro.2025.10.003_bib0002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.18.00419","article-title":"Defining risk factors for chemotherapeutic intervention in infants with stage 4S neuroblastoma: A report from Children\u2019s Oncology Group study ANBLl0531","volume":"37","author":"Twist","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0003","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/SLA.0b013e31826cbbbd","article-title":"A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: A Children's Oncology Group study","volume":"256","author":"Nuchtern","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2025.10.003_bib0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2407-11-21","article-title":"Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy","volume":"11","author":"Simon","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2025.10.003_bib0005","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/pbc.24713","article-title":"Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy","volume":"61","author":"Valteau-Couanet","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.prro.2025.10.003_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2019.09.025","article-title":"Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma","volume":"124","author":"Tas","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2025.10.003_bib0007","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1200\/JCO.1991.9.5.789","article-title":"Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma","volume":"9","author":"Castleberry","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0008","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","article-title":"The International Neuroblastoma Risk Group (INRG) staging system: An INRG Task Force report","volume":"27","author":"Monclair","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0009","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0010","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0011","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1200\/JCO.1991.9.7.1181","article-title":"Postoperative treatment of nonmetastatic visible residual neuroblastoma: A Pediatric Oncology Group study","volume":"9","author":"Nitschke","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0012","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1200\/JCO.19.00919","article-title":"Maintaining outstanding outcomes using response- and biology-based therapy for intermediate-risk neuroblastoma: A report from the Children\u2019s Oncology Group study ANBL0531","volume":"37","author":"Twist","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0360-3016(02)04506-6","article-title":"Impact of radiotherapy for high-risk neuroblastoma: A Children\u2019s Cancer Group study","volume":"56","author":"Haas-Kogan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0014","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00043426-200312000-00005","article-title":"Primary tumor control in patients with stage 3\/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants","volume":"25","author":"Marcus","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0015","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/1097-0142(19870901)60:5<1066::AID-CNCR2820600523>3.0.CO;2-J","article-title":"Localized neuroblastoma. Surgical and pathologic staging","volume":"60","author":"de Bernardi","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2025.10.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.18_suppl.LBA3","article-title":"A phase III randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for high-risk neuroblastoma (HR-NB): A Children\u2019s Oncology Group (COG) study","volume":"34","author":"Park","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0017","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ijrobp.2009.03.068","article-title":"Locoregional tumor progression after radiation therapy influences overall survival in pediatric patients with neuroblastoma","volume":"76","author":"Pai Panandiker","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0018","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1200\/JCO.19.03316","article-title":"Prospective evaluation of radiation dose escalation in patients with high-risk neuroblastoma and gross residual disease after surgery: A report from the Children\u2019s Oncology Group ANBL0532 study","volume":"38","author":"Liu","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0019","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ijrobp.2008.10.069","article-title":"Excellent local control from radiation therapy for high-risk neuroblastoma","volume":"74","author":"Gatcombe","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0020","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijrobp.2014.07.019","article-title":"Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma","volume":"90","author":"Mazloom","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijrobp.2016.05.020","article-title":"Local control with 21-Gy radiation therapy for high-risk neuroblastoma","volume":"96","author":"Casey","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27009","article-title":"Dose-escalation is needed for gross disease in high-risk neuroblastoma","volume":"65","author":"Casey","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.prro.2025.10.003_bib0023","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ijrobp.2016.11.043","article-title":"Favorable local control from consolidative radiation therapy in high-risk neuroblastoma despite gross residual disease, positive margins, or nodal involvement","volume":"97","author":"Ferris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0024","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijrobp.2019.01.095","article-title":"Outcomes after proton therapy for treatment of pediatric high-risk neuroblastoma","volume":"104","author":"Hill-Kayser","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ijrobp.2004.07.719","article-title":"Risk factors for scoliosis in children with neuroblastoma","volume":"61","author":"Paulino","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0026","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/djp230","article-title":"Long-term outcomes in survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study","volume":"101","author":"Laverdi\u00e8re","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2025.10.003_bib0027","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ijrobp.2014.04.004","article-title":"Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma","volume":"89","author":"Polishchuk","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0028","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3857\/roj.2019.00353","article-title":"Patterns of recurrence after radiation therapy for high-risk neuroblastoma","volume":"37","author":"Jo","year":"2019","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.prro.2025.10.003_bib0029","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijrobp.2018.01.008","article-title":"Radiation therapy to sites of metastatic disease as part of consolidation in high-risk neuroblastoma: Can long-term control be achieved?","volume":"100","author":"Casey","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.10.003_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MPH.0000000000000264","article-title":"Outcomes after radiation therapy to metastatic sites in patients with stage 4 neuroblastoma","volume":"37","author":"Kandula","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.prro.2025.10.003_bib0031","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00066-020-01718-5","article-title":"Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German neuroblastoma trials NB97 and NB 2004","volume":"197","author":"Jazmati","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2025.10.003_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110343","article-title":"Estimation of the optimal radiotherapy utilization rate for childhood neuroblastoma","volume":"197","author":"Fukushima","year":"2024","journal-title":"Radiother Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025002589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025002589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:22:15Z","timestamp":1780039335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850025002589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1879850025002589"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2025.10.003","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy Outcomes of the National Protocol in Childhood Neuroblastomas: Turkish Society for Radiation Oncology Hematological Oncology, Pediatric Oncology, and TBI Working Group Study (TROD 03-004)","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2025.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}